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Abstract FKBPs define a subfamily of peptidyl-prolyl cis/trans
isomerases (PPIases). PPIases are known to play roles in
cellular protein folding, protein interactions and signal transduc-
tion. Here we describe NcFKBP22 from Neurospora crassa, a
novel type of FKBP. NcFKBP22 is synthesized as a precursor
protein with a cleavable signal sequence. In addition to a typical
FKBP domain in the amino-terminal part mature NcFKBP22
contains a novel second domain which is unique amongst all
known FKBPs. The amino acid composition of this carboxy-
terminal domain is highly biased. Secondary structure predic-
tions suggest that this domain may form an amphipathic K-helix.
The carboxy-terminus of NcFKBP22 is ^HNEL, a potential
endoplasmic reticulum (ER) retention signal, suggesting that
NcFKBP22 is a resident protein of the ER. ß 2000 Federation
of European Biochemical Societies. Published by Elsevier Sci-
ence B.V. All rights reserved.
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1. Introduction
Peptidyl-prolyl cis/trans isomerases (PPIases; EC 5.2.1.8.)
are enzymes able to catalyze the cis/trans isomerization of
Xaa^Pro bonds in oligopeptides and proteins (for reviews
see [1^5]). PPIases are ubiquitous and abundant proteins
and have been found in bacteria, fungi, plants, and mammals.
They belong to three structurally unrelated families, namely
the cyclophilins (CyPs), the FKBPs, and the parvulin-like
proteins. CyPs and FKBPs are characterized by their ability
to bind the immunosuppressant drugs cyclosporin A or
FK506/rapamycin, respectively. Due to their enzymatic activ-
ity, PPIases are able to accelerate slow refolding steps in cer-
tain proteins in vitro (see [2]). Mitochondrial CyPs from Neu-
rospora crassa [6,7] and yeast [8] have been shown to be part
of the protein folding machinery of the organelle involving
molecular chaperones [6,7].
Whether FKBPs are also involved in eukaryotic cellular
protein folding is not yet clear. Known functions of eukary-
otic FKBPs (e.g. the abundant FKBP12) are functional inter-
actions with other proteins, such as the rhyanodine receptor
of the endoplasmic reticulum (ER) membrane, the inositol-
1,4,5-trisphosphate receptor or the TGF receptors of the plas-
ma membrane (see [9]).
Here we describe the identi¢cation and characterization of a
novel type of FKBP in the ER of N. crassa, which in addition
to a functional FKBP domain contains a second, novel do-
main, which is not present in any other characterized FKBP.
2. Materials and methods
2.1. Growth of N. crassa and preparation of protein extract
Cultures of N. crassa wild type 74A and fkr-2 [10] were grown as
described [11]. Hyphae from 10 l cultures were harvested. Per 1 g
hyphae, 1.5 g quartz sand and 1 ml extraction bu¡er (10 mM Tris^
HCl, 150 mM NaCl, 1 mM EDTA, 5 mM DTT, 1 mM PMSF, 1%
Triton X-100, pH 7.4) were added, cells broken and total extract
prepared as described [11].
2.2. A⁄nity puri¢cation of N. crassa FKBPs
1 ml a⁄nity beads (ascomycin bound to Sepharose beads; gift from
Dr. U. Krieg) was equilibrated with 10 mM Tris^HCl, 150 mM NaCl,
1 mM EDTA, 0.1% Triton X-100, pH 7.4 (bu¡er H) in a column.
100^500 mg total protein was applied to the column. After extensive
washes with bu¡er H and bu¡er H without Triton X-100, speci¢cally
bound proteins were eluted with 20 mM glycine, pH 2.5. 1 ml frac-
tions were neutralized with Tris, precipitated using TCA and proteins
run on SDS^PAGE [12].
Antibodies in rabbits were prepared as described [13]. Amino-ter-
minal sequencing was done according to [15].
2.3. Cloning of a full-length cDNA encoding NcFKBP22
A Vgt11 library of N. crassa [13,14] was used for screening. One
positive clone contained a short cDNA insert encoding a carboxy-
terminal part of NcFKBP22. Reverse primers from this region were
used in combination with degenerate primers directed against the
amino-terminus to isolated a speci¢c NcFKBP PCR product, which
was ¢nally used in plaque hybridizations to isolate a full-length cDNA
(EMBL submission number AJ006297.1).
2.4. PPIase assays
Native NcFKBP22 was puri¢ed to homogeneity from N. crassa
(manuscript in preparation). To determine PPIase activity, the iso-
mer-speci¢c protease assay [16] was used. The assay contained
35 mM HEPES^KOH, pH 7.5, 7.6 nM NcFKBP22, 800 Wg/ml chy-
motrypsin and 80 WM succinyl-Phe-Pro-Phe-p-nitroanilide (Succ-Phe-
Pro-Phe-pNA). For determination of the sensitivity of NcFKBP22
towards FK506 and rapamycin, 1 mg/ml BSA was added to the re-
action mix and NcFKBP22 was preincubated for 15 min with various
concentrations of the inhibitors. Reaction temperature was 7‡C.
3. Results
3.1. A⁄nity puri¢cation of N. crassa FKBPs
The only known FKBP in N. crassa to date is NcFKBP13
[14]. NcFKBP13 is the receptor mediating the antifungal ac-
tion of FK506 in N. crassa [10]. NcFKBP13 has a dual loca-
tion in cytosol and mitochondria, both forms being encoded
by a single nuclear gene, most probably fkr-2 (manuscript in
preparation; see [17]).
In order to identify novel FKBPs, we used a⁄nity chroma-
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tography using the FK506 homolog ascomycin (see [9])
coupled to Sepharose beads.
Brie£y, Neurospora lysates were prepared in the presence of
1% Triton X-100 (to include soluble organellar proteins for
the analysis) and loaded onto an ascomycin-a⁄nity resin.
After extensive washes, speci¢cally bound proteins were eluted
by a shift of the pH from 7.4 to 2.5 and analyzed by SDS^
PAGE (see also Section 2).
Two proteins running with apparent molecular weights of
29 and 13 kDa could be routinely seen in N. crassa wild type
lysates (Fig. 1, lane 1/WT), the 13 kDa protein being more
prominent.
We suggested that a⁄nity-puri¢ed NcFKBP13 might be
identical to NcFKBP13 already described (see above; [14]).
Indeed, amino-terminal protein sequencing of the a⁄nity-pu-
ri¢ed FKBP13 (Fig. 1, lane 1/WT) yielded the sequence
TIPQLDGLQIEVQQEG (see Fig. 2A), which is identical to
the published sequence of NcFKBP13 [14], with the exception
that the initiator methionine is missing; this is obviously re-
moved post-translationally from the cytosolic protein. In the
case of the mitochondrial precursor protein, the presequence
is cleaved after methionine corresponding to methionine +1 in
the cytosolic protein (manuscript in preparation). This results
in identical NcFKBP13 proteins in both cytosol and mito-
chondria.
One class of FK506-resistant N. crassa mutants (fkr-2) has
lost immunodetectable NcFKBP13 [10]. This result is con-
¢rmed by ascomycin a⁄nity chromatography of fkr-2 lysates.
No NcFKBP13 can be seen fkr-2 lysates (Fig. 1, lane 2/fkr-2).
However, in addition to NcFKBP13, a second FKBP ap-
pears in lysates of the wild type strain, which runs with an
apparent molecular weight of 29 kDa in SDS^PAGE (for
reasons mentioned below, we named it NcFKBP22). From
fkr-2 lysates, NcFKBP22 can be isolated as the only apparent
ascomycin-binding protein (Fig. 1, lane 2/fkr-2).
In order to characterize the protein, a⁄nity-puri¢ed
NcFKBP22 was used for amino-terminal sequencing and for
the production of rabbit antisera.
3.2. Determination of the amino-terminal sequence of
NcFKBP22
A⁄nity-puri¢ed FKBP22 was blotted onto PVDF mem-
branes and subjected to automatic amino-terminal Edman
degradation [15]. 34 out of 36 amino acids could be identi¢ed
unambiguously. Comparison of the amino-termini of
NcFKBP22 with that of NcFKBP13 [14] revealed that we
had indeed identi¢ed a novel FKBP in N. crassa (see Fig.
2A). Out of 33 identi¢ed amino acids of NcFKBP22, 12 are
identical to FKBP13 (shown in bold in Fig. 2A).
3.3. Molecular cloning of a cDNA encoding NcFKBP22
A N. crassa cDNA library [13,14] cloned into expression
vector Vgt11 was screened using NcFKBP22 speci¢c antisera.
One clone proved to be NcFKBP22-speci¢c, but contained
only the carboxy-terminal region (data not shown). PCR re-
actions, making use of the known amino-terminal sequence
(see Fig. 2A) ¢nally yielded a full-length cDNA.
The deduced amino acid sequence of NcFKBP22 is shown
in Fig. 2B.
Obviously, NcFKBP22 is made as a precursor protein with
20 additional amino acids at the amino-terminus. The precur-
sor protein is 217 amino acids in length. The additional se-
quence is a typical presequence for entry of the precursor
protein into the ER [18]. A basic amino acid at the amino-
Fig. 1. Ascomycin binding proteins of N. crassa. Lysates from wild
type N. crassa (WT; lane 1) and the FK506-resistant mutant fkr-2
(lane 2) were prepared as described in Section 2. 100 mg protein
was bound to the ascomycin matrix, washed extensively and bound
proteins eluted by a shift of the pH to 2.5. Eluted 1 ml fractions
were neutralized, precipitated by TCA, run on SDS^PAGE and
stained with Coomassie blue.
Fig. 2. NcFKBP22 is synthesized as an ER precursor protein; the
mature protein contains a novel domain. A: Comparison of amino-
terminal sequences of NcFKBP22 and NcFKBP13, respectively.
B: Amino acid sequence of NcFKBP22 precursor derived from the
cDNA sequence; the cleavage site of signal peptidase is indicated by
an arrow; a putative ER retention signal (^HNEL) is indicated in
bold print. C: Domain organization of mature NcFKBP22.
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terminus (lysine at position 2) is followed by a stretch of
hydrophobic residues. Cleavage by the signal peptidase obvi-
ously occurs after GVLA, AEEL being the amino-terminus of
the mature protein (Fig. 2B; cleavage site is indicated by an
arrow).
Calculated from the cDNA sequence, the mature protein
(197 amino acids) has a molecular weight of 20 912 Da. Elec-
trospray mass spectroscopy of a⁄nity-puri¢ed protein, how-
ever yielded a mass of 22 043 Da (manuscript in preparation).
Therefore, the protein was named NcFKBP22. The nature of
the post-translational modi¢cation resulting in an increase of
the molecular weight of 1131 Da is yet unknown (preliminary
results suggest that NcFKBP22 might be glycosylated; see
Section 4
The extreme carboxy-terminus of NcFKBP22 contains a
putative N. crassa ER retention signal (^HNEL; shown in
bold in Fig. 2B); we, therefore, propose that NcFKBP22 is
a resident protein of the ER.
The amino-terminal part of NcFKBP22 (residues 1^115) is
a typical FKBP domain; the highest amino acid identities of
the core FKBP region are to cytosolic/mitochondrial N. crassa
NcFKBP13 (60%; see Fig. 3A), Vicia faber FKBP15 (55%;
Fig. 3. NcFKBP22 contains a typical FKBP domain at the amino-terminal end and a novel carboxy-terminal domain capable of forming an
amphipathic K-helix. A: Sequence comparison of N. crassa NcFKBP22 and NcFKBP13 [14]. Identical residues are heavy shaded; in the car-
boxy-terminal part of NcFKBP22, basic residues are lightly shaded and acidic residues are medium shaded. B: ‘Helical net’ diagram [22] of res-
idues 123^168 of mature NcFKBP22. Acidic residues are medium shaded, basic residues are lightly shaded. For reasons of clarity, residues are
not interconnected.
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see [19]) and ER-localized human FKBP13 (53%; see [21])
and yeast FKBP13 (50%; see [20]). All residues important
for PPIase activity and FK506/rapamycin binding (see [9])
are present in the FKBP domain of NcFKBP22.
However, NcFKBP22 is unique amongst known FKBPs in
containing an unusual carboxy-terminal domain (residues
116^197), which has no homology to a domain in any other
known FKBP (see Fig. 3C). This carboxy-terminus (82 resi-
dues) contains an unusually high number of acidic residues
(14 Glu and 5 Asp residues versus 10 Lys and no Arg resi-
dues).
Also, the amino acid composition of the carboxy-terminal
domain of NcFKBP22 is clearly biased (see Table 1; compar-
ing amino acid composition of the N-terminal FKBP domain
(residues 1^115) to the C-terminal domain (residues 116^
197)). Ala, Glu, Lys and Val are overrepresented, while there
is a clear bias against Phe, Gly, Ile, Leu, Pro and Arg.
Secondary structure predictions according to Garnier-Rob-
son predict that residues 116^197 form an amphipathic K-
helix, with residues 166^189 being more hydrophobic than
the rest. In a helical net diagram [22], residues 123 to 168
form a perfect amphipathic helix where hydrophobic, acidic
and basic residues, respectively, are in distinct areas of the
proposed K-helix (Fig. 3B).
BLAST searches [23] using the the carboxy-terminal do-
main (residues 116^197) reveal a low sequence similarity (ap-
proximately 30% sequence identity; data not shown) to short
regions from late embryogenesis abundant (LEA) proteins
from di¡erent plant species like wheat [23], barley, cotton or
Arabidopsis thaliana (see [25,26]). During periods of water
de¢cit, plants accumulate LEA proteins which are thought
to protect cells from stress associated with dehydration. A
tomato LEA protein confers salt and freezing tolerance
when expressed in Saccharomyces cerevisiae [27]. The wheat
LEA protein Em functions as an osmoprotective molecule in
yeast [24]. Whether the carboxy-terminal domain of
NcFKBP22 might have a similar function in the ER of N.
crassa has to be determined.
3.4. PPIase activity of NcFKBP22
NcFKBP22 was puri¢ed to homogeneity from N. crassa
hyphae using standard biochemical techniques (manuscript
in preparation). PPIase activity of native NcFKBP22 was
measured using the isomer speci¢c protease assay [16]. As a
substrate succinyl-Phe-Pro-Phe-pNA (see Section 2) was used.
NcFKBP22 exhibits PPIase activity with a kcat/KM value of
6.94U105 M31 s31. As expected (see Fig. 4), the enzymatic
activity can be inhibited by FK506 (Ki = 4.5 nM) and rapa-
mycin (Ki = 6.2 nM).
4. Discussion
We have identi¢ed a novel type of FKBP in N. crassa.
NcFKBP22 is synthesized with a presequence of 20 amino
acids which is cleaved upon entry into the ER. Indeed, mature
NcFKBP22 can be isolated from luminal fractions of N. cras-
sa microsomes (manuscript in preparation).
Mature NcFKBP22 is composed of an amino-terminal
FKBP domain and a unique carboxy-terminal domain. As
expected from the sequence [9], the FKBP domain is active
as a FK506- and rapamycin-sensitive PPIase. The carboxy-
terminal domain is unique and its amino acid composition
is highly biased (Table 1). There is a preference for charged
amino acids and for alanine. Based on secondary structure
predictions, the carboxy-terminal domain of NcFKBP22
forms a perfect amphipathic K-helix (see Fig. 3B). No known
FKBP contains a similar domain. There is some similarity,
however, to region in proteins which occur in high amounts
in plant LEAs. The functions of these proteins are thought to
be maintenance of ion and water homeostasis [24].
NcFKBP22 is modi¢ed posttranslationally. The nature of
this modi¢cation is still unclear. Experimental evidence for a
possible glycosylation (data not shown) is that NcFKBP22
reacted positive in a PAS glycoprotein stain [28]. However,
NcFNBP22 does not contain a consensus sequence for N-gly-
cosylation and a variety of di¡erent lectins (GNA, SNA,
MAA, DSA and PNA) did not bind to NcFKBP22; so the
nature of the posttranslational modi¢cation remains to be
determined.
What might be the function of NcFKBP22?
We suggest that it might be involved in folding and/or
transport of certain proteins in the ER. The charged car-
boxy-terminus might interact with complementary regions in
target proteins. Since FKBPs show a narrow substrate specif-
Table 1
The C-terminal domain of NcFKBP22 has a biased amino acid
composition
Amino acid Amino-terminus Carboxy-terminus
Ala 2.6 23.2
Glu 7.0 17.1
Phe 3.5 0
Gly 14.8 3.7
Ile 7.8 2.5
Lys 6.1 12.2
Leu 6.1 1.2
Pro 7.0 0
Arg 5.2 0
Val 7.0 15.9
Amino acid frequencies in % in the FKBP domain of NcFKBP22
(amino-terminus; residues 1^115 of the mature protein; see Fig. 3A)
and the carboxy-terminal domain (residues 116^197 of the mature
protein). Only those amino acids which di¡er by more than 3% are
shown.
Fig. 4. PPIase activity of NcFKBP22 is inhibited by both FK506
and rapamycin. NcFKBP22 was preincubated with FK506 and ra-
pamycin, respectively, and residual activity was measured as de-
scribed in Section 2. Ki values were calculated according to [31].
FEBS 24016 28-8-00
B. Solscheid, M. Tropschug/FEBS Letters 480 (2000) 118^122 121
icity [29], the folding activity of NcFKBP22 might only reach
a limited subset of ER proteins. yFKBP13, the product of the
FKB2 gene in S. cerevisiae, is regulated in response to accu-
mulation of unfolded proteins in the ER [30]. There is some
evidence that PPIases might be involved in protein folding in
the ER (see [4]).
Since the carboxy-terminus of NcFKBP22 shares homology
to LEAs in plants cells, the possibility exists that NcFKBP22
might also be part of the ER system which is responsible for
ion and water homeostasis.
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